{"data":[{"accessionNo":"0001104659-26-097422","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"Pliant Therapeutics, Inc.","ticker":"PLRX","cusip":"729139105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"ADAR1 Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":5509724,"percentOfClass":8.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-097422","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"Pliant Therapeutics, Inc.","ticker":"PLRX","cusip":"729139105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Daniel Schneeberger","reportingCik":null,"personType":"HC,IN","sharesOwned":5509724,"percentOfClass":8.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-097105","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":"729139105","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Kenneth Griffin","reportingCik":null,"personType":"HC,IN","sharesOwned":2143426,"percentOfClass":3.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-097105","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":"729139105","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel Advisors Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":1418022,"percentOfClass":2.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-097105","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":"729139105","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":1418022,"percentOfClass":2.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-097105","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":"729139105","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel Advisors LLC","reportingCik":null,"personType":"IA,HC,OO","sharesOwned":1418022,"percentOfClass":2.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-097105","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":"729139105","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel Securities Group LP","reportingCik":null,"personType":"HC,PN","sharesOwned":725404,"percentOfClass":1.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-097105","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":"729139105","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel Securities GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":725404,"percentOfClass":1.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-097105","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":"729139105","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel Securities LLC","reportingCik":null,"personType":"BD,OO","sharesOwned":673114,"percentOfClass":1.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0000902664-26-001064","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Woodline Partners LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2026191,"percentOfClass":3.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0000902664-26-001134","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":46537,"percentOfClass":0.1,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0000902664-26-001134","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":46537,"percentOfClass":0.1,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0000902664-26-001134","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":46537,"percentOfClass":0.1,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-012206","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-02-02","reportingPerson":"Kenneth Griffin","reportingCik":null,"personType":"HC,IN","sharesOwned":3042133,"percentOfClass":5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-012206","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-02-02","reportingPerson":"Citadel Advisors LLC","reportingCik":null,"personType":"IA,HC,OO","sharesOwned":2099798,"percentOfClass":3.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-012206","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-02-02","reportingPerson":"Citadel Advisors Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":2099798,"percentOfClass":3.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-012206","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-02-02","reportingPerson":"Citadel GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":2099798,"percentOfClass":3.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-012206","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-02-02","reportingPerson":"Citadel Securities Group LP","reportingCik":null,"personType":"HC,PN","sharesOwned":942335,"percentOfClass":1.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-012206","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-02-02","reportingPerson":"Citadel Securities LLC","reportingCik":null,"personType":"BD,OO","sharesOwned":913609,"percentOfClass":1.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-012206","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-02-02","reportingPerson":"Citadel Securities GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":942335,"percentOfClass":1.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-008792","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-01-23","reportingPerson":"Kenneth Griffin","reportingCik":null,"personType":"HC,IN","sharesOwned":3037695,"percentOfClass":4.9,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-008792","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-01-23","reportingPerson":"Citadel Advisors Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":2099798,"percentOfClass":3.4,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-008792","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-01-23","reportingPerson":"Citadel GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":2099798,"percentOfClass":3.4,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-008792","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-01-23","reportingPerson":"Citadel Advisors LLC","reportingCik":null,"personType":"IA,HC,OO","sharesOwned":2099798,"percentOfClass":3.4,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-008792","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-01-23","reportingPerson":"Citadel Securities LLC","reportingCik":null,"personType":"BD,OO","sharesOwned":909171,"percentOfClass":1.5,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-008792","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-01-23","reportingPerson":"Citadel Securities Group LP","reportingCik":null,"personType":"HC,PN","sharesOwned":937897,"percentOfClass":1.5,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-008792","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-01-23","reportingPerson":"Citadel Securities GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":937897,"percentOfClass":1.5,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-005905","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-01-14","reportingPerson":"Kenneth Griffin","reportingCik":null,"personType":"HC,IN","sharesOwned":2991915,"percentOfClass":4.9,"filedAt":"2026-01-22","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-005905","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-01-14","reportingPerson":"Citadel Advisors Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":2099798,"percentOfClass":3.4,"filedAt":"2026-01-22","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-005905","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-01-14","reportingPerson":"Citadel GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":2099798,"percentOfClass":3.4,"filedAt":"2026-01-22","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-005905","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-01-14","reportingPerson":"Citadel Advisors LLC","reportingCik":null,"personType":"IA,HC,OO","sharesOwned":2099798,"percentOfClass":3.4,"filedAt":"2026-01-22","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-005905","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-01-14","reportingPerson":"Citadel Securities Group LP","reportingCik":null,"personType":"HC,PN","sharesOwned":892117,"percentOfClass":1.5,"filedAt":"2026-01-22","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-005905","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-01-14","reportingPerson":"Citadel Securities GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":892117,"percentOfClass":1.5,"filedAt":"2026-01-22","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001104659-26-005905","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-01-14","reportingPerson":"Citadel Securities LLC","reportingCik":null,"personType":"BD,OO","sharesOwned":863391,"percentOfClass":1.4,"filedAt":"2026-01-22","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0000895421-26-000001","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC","ticker":"PLRX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Morgan Stanley","reportingCik":null,"personType":"HC,CO","sharesOwned":545228,"percentOfClass":0.9,"filedAt":"2026-01-08","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0000902664-25-005034","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001746473","issuerName":"PLIANT THERAPEUTICS, INC.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Woodline Partners LP","reportingCik":null,"personType":"IA,PN","sharesOwned":4504817,"percentOfClass":7.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001172661-25-004832","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001746473","issuerName":"Pliant Therapeutics, Inc.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001172661-25-004832","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001746473","issuerName":"Pliant Therapeutics, Inc.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"},{"accessionNo":"0001172661-25-004832","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001746473","issuerName":"Pliant Therapeutics, Inc.","ticker":"PLRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/plrx"}],"updatedAt":"2026-11-04T07:05:29.008Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/plrx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}